ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed
Awalpreet Singh Chadha
Matched on ORCID iD 0000-0002-8072-2243; OpenAlex author ID A5091428708. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2015: 1 paper · 2016: 3 papers · 2017: 1 paper
Papers 5
- Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy? Co-author DOI 10.1016/j.ijrobp.2016.10.046↗
- Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolida… First author DOI 10.1016/j.ijrobp.2015.12.003↗
- Recent Advances and Prospects for Multimodality Therapy in Pancreatic Cancer. Co-author DOI 10.1016/j.semradonc.2016.05.002↗
- Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer. Co-author DOI 10.1371/journal.pone.0156910↗
- Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer. Co-author DOI 10.3109/0284186x.2014.1000466↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sunil Krishnan Krishnan · 5 shared papers, 2015–2017 · strength 0.26
- Paper Recent Advances and Prospects for Multimodality Therapy in Pancreatic Cancer. DOI 10.1016/j.semradonc.2016.05.002↗
- Paper Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy? DOI 10.1016/j.ijrobp.2016.10.046↗
- Paper Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiv… DOI 10.1016/j.ijrobp.2015.12.003↗
- Milind M. Javle · 4 shared papers, 2015–2017 · strength 0.19
- Paper Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy? DOI 10.1016/j.ijrobp.2016.10.046↗
- Paper Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiv… DOI 10.1016/j.ijrobp.2015.12.003↗
- Paper Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pa… DOI 10.1371/journal.pone.0156910↗
- Matthew H. G. Katz · 4 shared papers, 2015–2017 · strength 0.19
- Paper Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy? DOI 10.1016/j.ijrobp.2016.10.046↗
- Paper Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiv… DOI 10.1016/j.ijrobp.2015.12.003↗
- Paper Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pa… DOI 10.1371/journal.pone.0156910↗
- Robert A. Wolff · 4 shared papers, 2015–2017 · strength 0.19
- Paper Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy? DOI 10.1016/j.ijrobp.2016.10.046↗
- Paper Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiv… DOI 10.1016/j.ijrobp.2015.12.003↗
- Paper Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pa… DOI 10.1371/journal.pone.0156910↗
- Jason B. Fleming · 4 shared papers, 2015–2017 · strength 0.19
- Paper Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy? DOI 10.1016/j.ijrobp.2016.10.046↗
- Paper Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiv… DOI 10.1016/j.ijrobp.2015.12.003↗
- Paper Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pa… DOI 10.1371/journal.pone.0156910↗
- Gauri Rajani Varadhachary · 4 shared papers, 2015–2017 · strength 0.19
- Paper Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy? DOI 10.1016/j.ijrobp.2016.10.046↗
- Paper Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiv… DOI 10.1016/j.ijrobp.2015.12.003↗
- Paper Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pa… DOI 10.1371/journal.pone.0156910↗
- Christopher H. Crane · 4 shared papers, 2015–2017 · strength 0.19
- Paper Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy? DOI 10.1016/j.ijrobp.2016.10.046↗
- Paper Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiv… DOI 10.1016/j.ijrobp.2015.12.003↗
- Paper Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pa… DOI 10.1371/journal.pone.0156910↗
- Gabriel Oliveira Sawakuchi · 2 shared papers, 2016–2017 · strength 0.10
- Huamin Wang · 1 shared paper, 2016 · strength 0.05
- Deyali Chatterjee · 1 shared paper, 2016 · strength 0.05
- Pankaj Kumar Singh · 1 shared paper, 2016 · strength 0.05
- Mediha Ahmad · 1 shared paper, 2015 · strength 0.04
- Sushovan Guha · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.